First Time Loading...

Aveo Pharmaceuticals Inc
NASDAQ:AVEO

Watchlist Manager
Aveo Pharmaceuticals Inc Logo
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Watchlist
Price: 15 USD Market Closed
Updated: May 29, 2024

Aveo Pharmaceuticals Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aveo Pharmaceuticals Inc
Long-Term Debt Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Aveo Pharmaceuticals Inc
NASDAQ:AVEO
Long-Term Debt
$27.2m
CAGR 3-Years
46%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Debt
$63.8B
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
16%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Debt
$21.5B
CAGR 3-Years
-8%
CAGR 5-Years
-2%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Long-Term Debt
$60.1B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Debt
$361.5m
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
-4%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Debt
$2.7B
CAGR 3-Years
11%
CAGR 5-Years
31%
CAGR 10-Years
18%

See Also

What is Aveo Pharmaceuticals Inc's Long-Term Debt?
Long-Term Debt
27.2m USD

Based on the financial report for Sep 30, 2022, Aveo Pharmaceuticals Inc's Long-Term Debt amounts to 27.2m USD.

What is Aveo Pharmaceuticals Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
14%

Over the last year, the Long-Term Debt growth was -18%. The average annual Long-Term Debt growth rates for Aveo Pharmaceuticals Inc have been 46% over the past three years , 14% over the past five years .